Skip to main content
Year archive

VITASORA HEALTH LIMITED — 2016 filings

All 37 regulatory filings released by VITASORA HEALTH LIMITED (VHL) in 2016, sourced directly from the official regulator.

37 Filings
2016 Period
2016 filings (37)
Filing Released Lang
Appendix 3B - Issue of Capital from AGM Resolutions 10 pages 858.6KB
Capital/Financing Update
2016-12-19 English
Appendix 3Y - Change of Director's Interst Notices (x3) 6 pages 459.1KB
Director's Dealing
2016-12-19 English
Overnight Monitoring Product Accelerated 1 page 511
Regulatory Filings
2016-12-14 English
Chairman's Address to Shareholders 3 pages 343.2KB
AGM Information
2016-11-21 English
Results of Respiri 2016 Annual General Meeting 1 pa
Declaration of Voting Results & Voting Rights Announcements
2016-11-21 English
Respiri Market Update - November 2016 13 pages 1.7MB
Investor Presentation
2016-11-14 English
UK Offers Scope for Respiri to Develop Key Partnerships 2 pages 93.9KB
Capital/Financing Update
2016-11-08 English
Appendix 3Z - Final Director's Interest Notices (DH & RBH) 4 pages 144.8KB
Director's Dealing
2016-10-25 English
Appendix 4C - First Quarter Cash Report - FY2017 5 pages 131.4KB
Interim / Quarterly Report Q1 2017
2016-10-25 English
Notice of Annual General Meeting/Proxy Form 22 pages 725.5KB
AGM Information
2016-10-20 English
Respiri's Continued Leadership in Asthma Monitoring 2 pages 83.9KB
Regulatory Filings
2016-08-30 English
Appendix 4E & Annual Financial Report (30 June 2016) 62 pages 1.2MB
Annual Report FY 2016
2016-08-30 English
Appendix 4G - Corporate Governance Disclosure Document 9 pages 132.8KB
Governance Information
2016-08-30 English
Appendix 4C - Fourth Quarter Cash Report - FY2016 5 pages 100.4KB
Interim / Quarterly Report Q4 2016
2016-07-28 English
Independent Study Confirms AirSonea Detects Asthma Wheezing 1
Regulatory Filings
2016-07-24 English
Response to ASX Price Query 5 pages 298.5KB
Regulatory Filings
2016-07-11 English
Appendix 3Y - Change in Directors Interest Notices (x5) 10 pages 199.9KB
Director's Dealing
2016-06-23 English
Allotment of Rights Issue Securities & Top 20 Shareholders 2 pages 234.9KB
Capital/Financing Update
2016-06-22 English
Respiri $4.3M Rights Issue Closes With Success 1 pa
Capital/Financing Update
2016-06-16 English
Respiri Receives Strong Interest from Asia 1 page 1
Capital/Financing Update
2016-06-08 English
Respiri Announces $4.3M Fully Underwritten Rights Issue 4 pages 376.5KB
Capital/Financing Update
2016-05-18 English
Reinstatement to Official Quotation 1 page 85.3KB
Capital/Financing Update
2016-05-18 English
Appendix 3B 10 pages 150.5KB
Capital/Financing Update
2016-05-18 English
Section 708A Notice 1 page 319.9KB
Regulatory Filings
2016-05-18 English
Section 708AA Notice 3 pages 345.8KB
Capital/Financing Update
2016-05-18 English
Letter to Optionholders - Rights Issue 2 pages 431.2KB
Capital/Financing Update
2016-05-18 English
Offer Booklet for Renounceable Pro-Rata Rights Issue 37 pages 253.0KB
Capital/Financing Update
2016-05-18 English
Letter to Eligible Shareholders - Rights Issue 2 pages 431.0KB
Capital/Financing Update
2016-05-18 English
Letter to Ineligible Shareholders - Rights Issue 2 pages 493.7KB
Capital/Financing Update
2016-05-18 English
Respiri Company Presentation - May 2016 47 pages 5.9MB
Regulatory Filings
2016-05-18 English
Suspension from Official Quotation 2 pages 369.8KB
Capital/Financing Update
2016-05-17 English
Trading Halt 2 pages 369.0KB
Capital/Financing Update
2016-05-15 English
Appendix 4C - quarterly 5 pages 362.3KB
Interim / Quarterly Report Q3 2016
2016-04-27 English
Respiri Appendix 4D and Interim Financial Report - Dec 2015 19 pages 854.1KB
Interim / Quarterly Report H1 2016
2016-02-28 English
Respiri - Market Update (Feb 2016) 1 page 242.3KB
Capital/Financing Update
2016-02-28 English
Appendix 4C - Second Quarter Cash Report - FY2016 5 pages 418.9KB
Interim / Quarterly Report Q2 2016
2016-01-28 English
Appendix 3Y - Change in Directors Interest Notice (RBH) 2 pages 255.3KB
Director's Dealing
2016-01-04 English